Subscribe to our feed.

Purdue technology being commercialized to test cancer drugs' benefit to individual patients

September 30, 2014 — WEST LAFAYETTE, Ind. - An official at a life sciences startup based on a Purdue University innovation says his company may help oncologists see faster than ever which drug therapies will benefit cancer patients and to what extent.Steve Ouellette, co-founder and chief technology officer at KinaSense, said oncologists have no way to predict at the start of therapy which drugs will benefit a patient. An oncologist chooses an option from a group of drugs, administers it and waits to see if it works. Read More

Purdue-based pharmaceutical startup creates prefabricated drug dosages to support patient-centric medicine

September 25, 2014 — WEST LAFAYETTE, Ind. - Officials of a pharmaceutical startup based on a Purdue University innovation say their company is creating prefabricated drug dosages that could be used by compounding pharmacists to support patient-centered medicine. Read More